MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, 

MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ
Marketwired
MethylGene Inc. Logo
View Comments